Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Results in Patients with Coronary Artery Disease and in patients with Peripheral Artery Disease.

Back

ESC Premium Access

Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Results in Patients with Coronary Artery Disease and in patients with Peripheral Artery Disease.

Session: Hot Line: Late-Breaking Clinical Trials 1

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor L. Wallentin (Uppsala, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)

18 presentations

1 follower

14 more presentations in this session

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study

Speaker: Professor I. Van Gelder (Groningen, NL)

Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study.

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Panel discussion.

Access

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor N. Marrouche (New Orleans, US)

Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Access the full session

Hot Line: Late-Breaking Clinical Trials 1

Speakers: Professor L. Wallentin, Professor I. Van Gelder, Professor J. Brugada Terradellas, Professor N. Marrouche, Professor C. Blomstrom-Lundqvist

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources